• If you are wondering whether Veeva Systems at US$158.49 is starting to look like value or still prices in high expectations, the next sections walk through what the numbers say about the stock.
• The share price has fallen 3.9% over the past week, 1.2% over the past month, and is down 27.8% year to date and 32.4% over the last year, which can change how the market views both risk and potential reward.
• These moves sit against a backdrop where investors continue to focus on Veeva Systems' role in cloud software for life sciences and how that positioning fits current sentiment toward healthcare technology stocks. Broader conversations around valuation, growth expectations, and quality in the sector are helping shape how quickly investors are willing to re rate software companies after share price declines.
• Veeva Systems currently has a valuation score of 4 out of 6. The rest of this article will compare what different valuation methods suggest about that score and then finish with a framework that can help you assess whether those methods really capture the full picture.

Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth today by projecting future cash flows and discounting them back to a present value. It focuses on the cash the company is expected to generate for shareholders over time.

For Veeva Systems, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $1.39b. Analyst and extrapolated estimates suggest free cash flow of around $2.43b by the 2031 financial year, with ten year projections supplied and then extended by Simply Wall St beyond the typical five year analyst window.

Putting all of those projected cash flows together and discounting them back results in an estimated intrinsic value of about $296.36 per share. Compared with the recent share price of $158.49, the model indicates the stock is priced below this cash flow estimate.

Result: UNDERVALUED (based on this DCF model)

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 46.5%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

Approach 2: Veeva Systems Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about value because it links what you pay for each share to the earnings that support that share. Higher growth potential and lower perceived risk usually justify a higher P/E, while slower growth or higher risk tend to anchor the ratio closer to, or below, the market and industry averages.

Veeva Systems trades on a P/E of 28.46x. That sits above the Healthcare Services industry average P/E of 26.38x, but below the peer group average of 32.64x. Simply Wall St also calculates a proprietary “Fair Ratio” for Veeva Systems of 29.09x. This Fair Ratio is designed to estimate what a reasonable P/E could be for this specific company by incorporating factors like its earnings growth profile, profit margins, industry, market cap and risk characteristics.

Because the Fair Ratio is tailored to the company, it can be a more precise guide than a simple comparison with peers or the broad industry, which may have very different growth, profitability and risk. With Veeva Systems at 28.46x versus a Fair Ratio of 29.09x, the P/E suggests the stock is slightly below that tailored estimate of fair value.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Veeva Systems Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so this is where Narratives come in, giving you a clear story behind the numbers by linking your view of Veeva Systems to a forecast for revenue, earnings and margins, and then to a Fair Value that you can compare with the current share price to decide whether the stock looks attractive or expensive.

On Simply Wall St's Community page, Narratives are a simple tool used by millions of investors that lets you set out your assumptions, see the implied Fair Value, and then watch that view update as new information like news or earnings arrives, so your decision making is not tied to a one off snapshot.

For Veeva Systems, for example, one investor might build a bullish Narrative that lines up with a Fair Value near US$380.00, while another might use more cautious assumptions that point closer to US$232.80, and by comparing each Narrative's Fair Value with the current price you can quickly see which story, and which set of assumptions, you find more reasonable.

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.